Frontiers Current Pharmacological Strategies for Duchenne

Por um escritor misterioso

Descrição

Frontiers  Current Pharmacological Strategies for Duchenne
Frontiers Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata
Frontiers  Current Pharmacological Strategies for Duchenne
Cells, Free Full-Text
Frontiers  Current Pharmacological Strategies for Duchenne
Duchenne muscular dystrophy - Wikipedia
Frontiers  Current Pharmacological Strategies for Duchenne
PDF) Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Frontiers  Current Pharmacological Strategies for Duchenne
Pharmacological strategies for muscular dystrophy
Frontiers  Current Pharmacological Strategies for Duchenne
Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy: Molecular Therapy - Methods & Clinical Development
Frontiers  Current Pharmacological Strategies for Duchenne
Stem Cell–Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy
Frontiers  Current Pharmacological Strategies for Duchenne
Frontiers Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
Frontiers  Current Pharmacological Strategies for Duchenne
Frontiers Drug development progress in duchenne muscular dystrophy
Frontiers  Current Pharmacological Strategies for Duchenne
Current advances in gene therapy of mitochondrial diseases, Journal of Translational Medicine
Frontiers  Current Pharmacological Strategies for Duchenne
Frontiers Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era
de por adulto (o preço varia de acordo com o tamanho do grupo)